Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00395746
Status:
COMPLETED
Last Update Posted:
2017-03-08
First Post:
2006-11-02
Brief Title:
Effect of Liraglutide in Combination With Sulfonylurea SU on Blood Glucose Control in Subjects With Type 2 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
Effect of Liraglutide in Combination With Sulfonylurea SU on Glycaemic Control in Subjects With Type 2 Diabetes
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in Japan The trial aims for comparison of the effect on glycaemic control of liraglutide in combination with sulphonylurea agent SU compared to SU monotherapy as assessed by HbA1c after 24 weeks and 52 weeks in subjects with type 2 diabetes Liraglutide will be compared to placebo in combination with SU Trial has a randomisation period of 24 weeks followed by a 28 week extension period in total 52 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| JapicCTI-060324 | REGISTRY | japic | None |